UnitedHealth Group Incorporated (UNH · NYSE)

UNH · MARKET VIEW

Market view · as of Aug 31, 2026

Revenue (TTM)
$450.53B
+0.4% YoY
Gross margin
19.7%
EPS (latest q)
$6.38
vs $4.94 est · beat
52-wk position
75.7%
-9.9% vs 52w high · -5.2% 1mo

Price (last ~year)

UnitedHealth Group (UNH) reported second-quarter 2026 revenue of $112.03 billion and earnings per share of $6.38, exceeding analyst estimates. Despite the earnings beat, the stock has declined 5.2% over the past month amid news of a lawsuit filed by Maryland regarding a Medicaid computer system. The company, valued at $352.71 billion, recorded a 61.5% year-over-year increase in earnings and generated $10.25 billion in free cash flow for the quarter.

Valuation

Market cap
$352.71B
P/E
25.38
PEG
1.217
P/B
3.602
P/S
0.783
EV/EBITDA
15.47
Beta
0.632
Analyst target
$475.23

Quality & returns

Gross margin
19.7%
Operating margin
7.1%
Profit margin
3.1%
ROE
14.1%
ROA
4.9%

Price movement

Last
$392.95
1-month
-5.2%
3-month
+4.8%
RSI (14)
38
vs SMA200
+13.2%
52-wk position
75.7% -9.9% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$112.03B$7.99B$5.48B$8.97B
2026-03-31$111.72B$8.99B$6.28B$10.09B
2025-12-31$113.22B$380.0M$10.0M$1.37B
2025-09-30$113.16B$4.32B$2.35B$5.33B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots